CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide

International Journal of Cancer. Journal International Du Cancer
Praveen K SharmaShailesh Singh

Abstract

Despite recent advances in treatment and management of prostate cancer (PCa), it remains the second leading cause of cancer-related deaths among men in the US. Chemotherapy is one of the treatment alternatives for hormone refractory metastatic PCa. However, current chemotherapeutic regimens provide palliative benefit but relatively modest survival advantage primarily due to chemo-resistance and upregulated antiapoptotic machineries in PCa cells. Therefore, blocking the mechanisms responsible for suppression of apoptosis might improve current chemotherapeutic regimens. In this study, we show that CC chemokine receptor-9 (CCR9) and its natural ligand CCL25 interaction upregulates antiapoptotic proteins (i.e., PI3K, AKT, ERK1/2 and GSK-3beta) and downregulate activation of caspase-3 in PCa cells. Significant downregulation of these CCR9-mediated antiapoptotic proteins in the presence of a PI3K inhibitor (wortmannin), further suggests that the antiapoptotic action of CCR9 is primarily regulated through PI3K. Furthermore, the cytotoxic effect of etoposide was significantly inhibited in the presence of CCL25, and this inhibitory effect of CCL25 was abrogated when CCR9-CCL25 interaction was blocked using anti-CCR9 monoclonal antibodie...Continue Reading

References

Jan 1, 1996·Advances in Pharmacology·S R Denmeade, J T Isaacs
Aug 11, 1998·Immunity·S G WardJ Westwick
Aug 26, 1998·The Journal of Laboratory and Clinical Medicine·B B MooreR M Strieter
Dec 5, 1998·Journal of Immunological Methods·J M WangS Su
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C R YuJ M Farber
Mar 16, 2001·Expert Opinion on Pharmacotherapy·J M Kamradt, K J Pienta
Oct 25, 2002·Journal of Cellular Biochemistry·Jenny M LeanTimothy J Chambers
May 23, 2003·Journal of Cellular Biochemistry·Yan-Xi SunRussell S Taichman
Apr 17, 2004·The Journal of Investigative Dermatology·Anne LetschCarmen Scheibenbogen
Oct 7, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Shailesh SinghJames W Lillard
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shailesh SinghJames W Lillard
Jan 14, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Yan-Xi SunRussell S Taichman
Aug 17, 2005·Current Medicinal Chemistry. Anti-cancer Agents·E L Baldwin, N Osheroff
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Farin F AmersiDave S B Hoon
Jun 28, 2008·Cell Death and Differentiation·M Z KhanO Meucci
Aug 13, 2008·Blood·Kirsten M WilliamsRonald E Gress
Aug 30, 2008·Current Opinion in Pharmacology·Timothy A YapPaul Workman
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 18, 2009·International Journal of Cancer. Journal International Du Cancer·Shailesh SinghJames W Lillard

❮ Previous
Next ❯

Citations

Mar 5, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Jie LiJinquan Tan
Feb 2, 2013·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Eileen L HeinrichJoseph Kim
Aug 7, 2012·The Journal of Clinical Investigation·Huanhuan Joyce ChenSteven Lipkin
Jun 4, 2011·International Journal of Oncology·Rajesh SinghShailesh Singh
Feb 18, 2016·Journal of Hematology & Oncology·Zhenbo TuQiuping Zhang
Feb 9, 2016·The Journal of Clinical Investigation·Nicolas JacquelotLaurence Zitvogel
Aug 12, 2014·BioMed Research International·Jiamin ZhouJi Ming Wang
Jan 28, 2014·Journal of Cellular Biochemistry·Xiao-Fei QiangLi-Hua Shi
Aug 1, 2015·PloS One·Heather L Evans-MarinYingzi Cong
May 31, 2017·Nature Reviews. Immunology·Nisha NagarshethWeiping Zou
Jan 13, 2018·Journal of Cellular Biochemistry·Shishir UpadhyayMonisha Dhiman
May 14, 2020·Journal of Cellular Physiology·Baoping XuYang Yang
Mar 25, 2019·BioMed Research International·Vanesa StojanovskaKulmira Nurgali
Feb 13, 2018·Frontiers in Immunology·Beatriz Somovilla-CrespoLeonor Kremer
Nov 17, 2020·Frontiers in Molecular Biosciences·Naoya NagayaIsaac Yi Kim
Jun 24, 2021·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Ren NanamiyaYukinari Kato
Aug 20, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bárbara MatosMargarida Fardilha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

© 2021 Meta ULC. All rights reserved